Spensus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 5.20 Cr
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.98 Cr
- Revenue Growth 48995.35%
- Profit Growth -15625.67%
- Net Worth -37.30%
- Total Assets 11.14%
About Spensus Pharmaceuticals
Spensus Pharmaceuticals Private Limited (SPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 February 2018 (Six years and 11 months 14 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.20 Cr.
The company currently has active open charges totaling ₹17.98 Cr.
Tanmay Patel and Nileshkumar Patel serve as directors at the Company.
Company Details
-
Location
Mahesana, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2018PTC100978
-
Company No.
100978
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Spensus Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanmay Patel
|
Director | 24-Feb-2018 | Current |
|
Nileshkumar Patel
|
Director | 24-Feb-2018 | Current |
Financial Performance of Spensus Pharmaceuticals.
Spensus Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 48995.35% increase. The company also saw a substantial fall in profitability, with a 15625.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 37.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spensus Pharmaceuticals?
In 2024, Spensus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Uma Metaldec Private LimitedNileshkumar Patel is a mutual person
Charges (Loans)
₹17.98 Cr
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 17.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2024 | Sidbi | ₹3.48 Cr | Open |
| 13 Jan 2022 | Sidbi | ₹5.00 M | Open |
| 13 Jan 2022 | Sidbi | ₹9.00 Cr | Open |
| 13 Jan 2022 | Sidbi | ₹5.00 Cr | Open |
How Many Employees Work at Spensus Pharmaceuticals?
Spensus Pharmaceuticals has a workforce of 4 employees as of Jan 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spensus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spensus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
